As infection progressed to 4 weeks, the number of α-SMA positive blood vessels remained similar in the PBS control group, but was significantly increased by Marimastat treatment (S6 Fig), indicating MMP inhibition increases pericyte-covered blood vessels over time. Here, ACTA1 is linked to infection.